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Gut resistome development in healthy twin
pairs in the first year of life
Aimee M. Moore1,3, Sara Ahmadi2,3, Sanket Patel2,3, Molly K. Gibson3, Bin Wang2,3, Malick I. Ndao1, Elena Deych4,
William Shannon4, Phillip I. Tarr1,5, Barbara B. Warner1 and Gautam Dantas2,3,6*

Abstract
Background: The early life of the human host marks a critically important time for establishment of the gut microbial
community, yet the developmental trajectory of gut community-encoded resistance genes (resistome) is unknown. We
present a longitudinal study of the fecal antibiotic resistome of healthy amoxicillin-exposed and antibiotic-naive twins
and their mothers during the first year of life.
Results: We extracted metagenomic DNA (mgDNA) from fecal samples collected from three healthy twin pairs at three
timepoints (1 or 2 months, 6 or 7 months, and 11 months) and from their mothers (collected at delivery). The mgDNA
was used to construct metagenomic expression libraries in an Escherichia coli host. These libraries were screened for
antibiotic resistance, and functionally selected resistance genes were sequenced and annotated. A diverse fecal
resistome distinct from the maternal resistome was apparent by 2 months of age, and infants’ fecal resistomes
included resistance to clinically important broad-spectrum beta-lactam antibiotics (e.g., piperacillin-tazobactam,
aztreonam, cefepime) not found in their mothers. Dissemination of resistance genes among members of a given
family was positively correlated with sharing of those same resistance genes between unrelated families, potentially
identifying within-family sharing as a marker of resistance genes emerging in the human community at large. Finally,
we found a distinct developmental trajectory for a community-encoded function: chloramphenicol resistance. All study
subjects at all timepoints harbored chloramphenicol resistance determinants, but multidrug efflux pumps (rarely found
in mothers) were the primary effectors of chloramphenicol resistance in young infants. Chloramphenicol acetyltransferases
were more common in mothers than in infants and were found in nearly all the infants at later timepoints.
Conclusions: Our results suggest that healthy 1–2-month-old infants’ gut microbes harbor clinically relevant resistance
genes distinct from those of their mothers, and that family-specific shared environmental factors early in life
shape resistome development.
Keywords: Antibiotic resistance, Gut microbiome, Fecal microbiome, Pediatrics, Beta lactamase, Chloramphenicol
resistance

Background
The human gut microbiota is an important reservoir of
antibiotic resistance genes (resistome), which can be exchanged with pathogens [1–4]. Diverse antibiotic resistance genes are present in the gut microbiota of young
infants soon after birth, even without antibiotic therapy
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[5–12]. While the overall architecture of the gut microbial community undergoes chaotic shifts in the first
years of life before stabilizing towards an adult-like state
[13–16], the trajectory and dynamics of resistome development in healthy young infants are poorly understood.
Children in the United States are heavily antibioticexposed [11, 12], with unclear effects on resistome development. In this study, we present a longitudinal functional
metagenomic interrogation of gut resistome development
during the first year of life in three pairs of healthy, vaginally delivered, formula-fed twins enrolled in the St. Louis
Neonatal Microbiome Initiative. One pair was antibioticnaïve for the entire sampling interval, one pair was

© 2015 Moore et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Moore et al. Microbiome (2015) 3:27

concordant (receiving 10 days of amoxicillin simultaneously at 8 months of age) and one was discordant (one
sibling received 10 days of amoxicillin at 8 months and
the other did not).

Results
Demographic information regarding the three families
included in this study is listed in Additional file 1: Table
S1. We constructed 21 fecal metagenomic libraries averaging 9.3 ± 7.9 (mean ± s.d.) gigabases (Gb) in size, from
18 infant samples and 3 maternal samples, and used
functional metagenomic selections paired with nextgeneration sequencing to identify a total of 905 unique
predicted antibiotic resistance protein clusters (collapsed
at 97 % amino acid identity using cd-hit [17, 18]). In all individuals, at all timepoints, we identified protein clusters
conferring resistance to five different antibiotic classes (βlactams, tetracycline, chloramphenicol, trimethoprim, and
cycloserine). Proteins conferring resistance to aminoglycosides, tigecycline, and colistin were also found, but less frequently. Of the 905 resistance protein clusters identified,
296 (32 %) were unique to mothers, 531 (59 %) were
unique to infants, 142 (15.6 %) were shared between twin
siblings, 159 (17.5 %) persisted within the same individual
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at multiple timepoints, and 106 (11.7 %) were shared between unrelated infants. Only 51 (5.6 %) were shared between infants and their mothers. Twin siblings’ resistomes
were significantly more similar to each other than to those
of their mothers or unrelated infants (p < 0.01, Student’s t-test with 1000 Monte Carlo simulations, Fig. 1).
Conversely, they were as similar to their siblings’ resistomes as they were to their own at other points in time
and no more similar to their mothers’ resistomes than
to unrelated infants’ resistomes (Fig. 1). There was no
difference in sharing between infants and their own
mothers and infants and unrelated mothers. When
sharing of resistance proteins between siblings was separated by individual timepoint, infant resistomes were significantly more similar to their twin sibling’s resistome
than to the resistome of an unrelated infant (p = <0.005,
all timepoints, Additional file 1: Figure S3). The composition of infant resistomes appears generally robust in the
face of amoxicillin perturbation: neither the overall population of resistance protein nor the specific sub-population
of β-lactamases was affected by amoxicillin exposure when
measured approximately 3 months after antibiotic
treatment. There was, however, a statistically significant
increase in the number of multidrug efflux pumps

Fig. 1 Twin infant fecal resistomes resemble those of their siblings. Predicted resistance proteins were collapsed into 97 % identity clusters. Binary
Jaccard resistance protein cluster composition similarity was determined for (1) the same infant at different timepoints (self-sharing), (2) twin
siblings, (3) unrelated infants, and (4) mothers and infants from the same family. a All resistance proteins at left; b the subset of β-lactamases and
penicillin-binding proteins at right. Significance was calculated using the Student’s t-test with 1000 Monte Carlo simulations (**p < 0.01). Infant
resistomes overall (a) were significantly more similar to a twin sibling or to the same subject at different timepoints than to their mothers or unrelated
infants. Infant resistomes were no more similar to those of their mothers than to unrelated infants. There was also no significant difference between
the similarity between infants and their twin sibling and the persistence of resistance proteins within a given individual at different
timepoints (self-sharing)
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conferring resistance to β-lactam antibiotics at 3 months
after amoxicillin exposure in these infants (p < 0.0001, loglinear model, Additional file 1: Table S3).
We used a log-linear model to test the likelihood that
resistance-associated protein clusters would be shared
within multiple members of a given family, or between unrelated families (Fig. 2). Although resistance-associated
proteins were less likely to be found in more than one
family member than in just one individual (p < 0.0001,
Additional file 1: Table S4) and less likely to be found in
multiple families than in a single family (p < 0.0001,
Additional file 1: Table S4), resistance proteins that were
found in more than one individual within a family were
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also significantly more likely to be found in more than one
family (p < 0.0001, Additional file 1: Table S4). We also
used a log-linear model to test the likelihood that
resistance-associated protein clusters that persisted within
a given individual at different timepoints were more likely
to be shared within and between families. Although resistance proteins were significantly less likely to be persistent
at multiple timepoints than found at a single timepoint
(p < 0.0001, Additional file 1: Table S10), and also less
likely to be found in multiple individuals than in a single individual (p < 0.0001, Additional file 1: Table S10),
resistance proteins that persisted within an individual
over time were also significantly more likely to be

Fig. 2 Sharing of resistance-associated proteins within and between families. The top graph shows absolute counts of resistance-associated protein
clusters, grouped by the number of members within a given family they were identified in. Most protein clusters were only identified in one member
of one family; much smaller numbers were identified in multiple family members or multiple families. The lower graph shows the proportions
of resistance-associated protein clusters identified in multiple families, grouped by the number of members of a single family they were identified in.
Larger proportions of resistance-associated proteins that are shared are multiple members of a single family are also identified in multiple
unrelated families
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found within multiple members of the same family (p =
0.0449). There was no significant interaction between
persistence of resistance proteins within an individual
over time and sharing between unrelated families.
We used a log-linear model to test the contribution of
co-localization with a mobile genetic element to sharing
of resistance protein clusters within members of a single
family and between unrelated families. One hundred
thirty-six of 905 (15.1 %) resistance-associated protein
clusters were encoded by genes co-localized with a mobile genetic element. However, this co-localization was
not significantly associated with sharing of a protein
cluster within members of a given family (p = 0.2212,
Additional file 1: Table S5) or between members of unrelated families (p = 0.2655, Additional file 1: Table S5).
β-lactam resistance was universal across the study cohort, yet there was substantial inter-subject variation in
the pattern of specific β-lactam resistance phenotypes
(Figs. 3 and 4 and Additional file 1: Figures S1 and S2).
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Only 5 of 47 (10.7 %) β-lactamase family proteins were
shared between infants and mothers, similar to the proportion shared with unrelated infants (4 of 47, or 8.5 %).
Consistent with trends observed in the general resistome, β-lactam resistance patterns were similar between
siblings and stable over time, where 11 of 47 (23.4 %) βlactamases and penicillin-binding proteins were shared
with the infants’ twin sibling and 13 of 47 (27.7 %) persisted within the same individual at multiple samplings.
Infant β-lactam resistomes were significantly more like
their own resistome at another timepoint or a twin sibling’s resistome than the resistome of an unrelated infant, and significantly more similar to their twin siblings’
than to their mothers’ resistomes (p < 0.01, Student’s t-test
with 1000 Monte Carlo simulations, Fig. 1b). When each
timepoint was analyzed separately, twin siblings’ resistomes were only significantly more similar to each other
than to those of an unrelated infant of the same age at
timepoint 2 (Additional file 1: Figure S3).

Fig. 3 β-lactamase phylogenetic tree. Predicted β-lactamase protein sequences were collapsed into 97 % ID clusters. All β-lactamase protein
sequences with at least 90 % coverage of the nearest hit in the NCBI nr database were included in the tree. Multiple alignment was done with
Muscle and the tree was made using FastTree. Nodes with an S-H value >0.7 are marked with a square. All classes of β-lactamases are present.
Class A β-lactamases separated into two groups: one with high identity to TEM extended-spectrum β-lactamases and one without. β-lactamases
co-localized with mobile genetic elements are marked with a gray dot. Novel β-lactamases with less than 70 % identity to any known β-lactamase are
marked with a star. β-lactamases found in cefepime selections are marked with a triangle
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Fig. 4 Populations of chloramphenicol resistance proteins change over time. Predicted proteins found when fecal metagenomic libraries were
screened on chloramphenicol-containing media were collapsed into 97 % ID clusters. Black boxes signify genes encoding a resistance protein that
were identified in the fecal metagenome of a study subject at a given timepoint, while white or light gray squares indicate that the protein was
not present. Proteins that were co-localized with a mobile genetic element are marked with an asterisk. Chloramphenicol acetyltransferases were
found in all mothers and in five of the six infants at the final timepoint, but were qualitatively less common in infants at earlier timepoints. By
contrast, multidrug efflux pumps were rare in mothers and in 11-month-old infants, but were commonly found in earlier samples

Chloramphenicol resistance was present in all subjects
at all timepoints. We observed distinct infantile and
adult-like populations of chloramphenicol resistance
genes. In the fecal samples collected in early infancy (1
or 2 months, and 6 or 7 months), chloramphenicol resistance genes primarily encoded multidrug efflux
pumps (Fig. 2). We used a log-linear model to test the
likelihood that multidrug efflux pumps were found in
mothers versus infants and that these pumps became
less common over time. Multidrug efflux pumps were
significantly more common in infants than in mothers
(p = 0.0009, Additional file 1: Table S6) and were significantly less likely to be found as infant age increased during
the first year of life (p < 0.0001, Additional file 1: Table S7).
A majority (85 %) of these efflux pumps had >90 % identity
to efflux pumps of Enterobacteriaceae origin; only one
(CL2137) was identical to a bifidobacterial major facilitator
transporter (WP_003817038). Some multidrug efflux
pumps originated from source contigs with sequences
identical to those of bona fide pathogens: a 3737 bp
contig from a 1-month-old infant (and a 1460 bp contig
from the twin sibling) had 100 % sequence identity to
the recently described pan-resistant Enterobacter aerogenes strain EA1509E [19].
While multidrug efflux pumps were the most common
effectors of chloramphenicol resistance in stools of
young infants, chloramphenicol acetyltransferases were
more frequently associated with maternal resistomes.
We used a log-linear model to test the likelihood that
chloramphenicol acetyltransferases were found in mothers
versus infants and that these acetyltransferases became
more common over time. Chloramphenicol acetyltransferases were significantly more common in mothers than

infants (p < 0.0001, Additional file 1: Table S8), were rarely
found in the youngest infants, but were found in five of
the six infants at the final (11-month) timepoint (Fig. 4).
There was, however, no significant increase over time
in the likelihood of finding chloramphenicol acetyltransferases in infant gut microbiomes (p = 0.2930,
Additional file 1: Table S9). Twenty-five percent of the
chloramphenicol acetyltransferases identified in this
study population were co-localized with mobile genetic
elements. Novel proteins made up more than half of
the chloramphenicol acetyltransferases identified in this
study: seven of the 12 chloramphenicol acetyltransferase clusters identified had <75 % protein identity to any
known acetyltransferase. The source contigs for these
novel resistance proteins also had low identity to any
known organism.

Discussion
In this study population, we found a diverse fecal resistome established within 1–2 months of birth. Prior
microbiome studies of twin infants have shown that siblings’ microbiomes undergo similar changes over time
[13] and are similar to each other irrespective of zygosity
[15, 20, 21]; the patterns of sharing of resistanceassociated proteins between twin siblings we observed
are consistent with this prior work on the overall microbial community, and likely reflect similarities between
siblings in microbial community composition. We also
found that infants’ gut resistomes differed from those of
their mothers in early life, which is also consistent with
studies showing that the gut microbiota of twin infants
are more similar to each other than to their mothers’
microbiota [20] and that infant gut-associated tetracycline
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resistance genes [6, 7] are distinct from those in the maternal fecal microbiota [6, 7]. The assembly of a diverse gut
resistome within the first 2 months of life, and the greater
resemblance of infant gut resistomes to their own and
their siblings’ resistomes at other timepoints than to the
resistomes of unrelated infants, suggest that familyspecific shared environmental factors early in life shape
resistome development. The dissimilarity of infant resistomes to those of their mothers suggests that, although
gut microbes may be shared between the mothers and vaginally delivered infants [22], the maternal gut resistome is
not the primary driver of gut resistome establishment in
infants. The previously observed pattern in which twin
siblings’ microbiomes are similar to each other and dissimilar to their mothers’ microbiome also applies to the
gut resistome, suggesting that the infants’ gut resistome is
likely a reflection of community composition.
In every family, phenotypic resistance to at least one
broad-spectrum β-lactam encoded by an infant gut resistome was not observed in the mothers’ resistome, although
the specific antibiotics involved (piperacillin-tazobactam,
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cefotaxime, aztreonam, and/or cefepime) varied (Figs. 3 and
5 and Additional file 1: Figure S1). The genetic dissimilarity
between infants’ beta-lactam resistomes and those of their
mothers likely explains this phenotypic difference, as phylogenetic groups of resistance genes were often associated
with specific β-lactam antibiotics. For example, one group
of class A β-lactamases with high identity to TEM βlactamases was associated with extended-spectrum
penicillin and β-lactamase inhibitor resistance (Fig. 3
and Additional file 1: Figure S2), while another class A
group was more closely associated with resistance to
later-generation cephalosporins. The origin of the
broader-spectrum beta-lactam resistance in infant gut
resistomes is unclear, although colonization with
antibiotic-resistant hospital bacterial strains is a possibility that warrants further study (all newborn subjects
were healthy hospital-born infants). However, we wish
to note that the multidrug-resistant pathogen Escherichia
coli ST131 does not colonize the infants in this cohort
until well after discharge from the hospital [23]. The lack
of time-dependent effects on β-lactam resistance genes

Fig. 5 β-lactam phylogenetic tree, annotated by study subject. Maternal subjects are marked with an “M”. Infant fecal samples are marked with a
number; “1” indicating the first (baseline) sample collected at 1–2 months of age, “2” indicating the second sample collected at 6–7 months of
age, and “3” indicating the third sample collected at 11 months of age. The antibiotic-naïve control family is colored green, the family with infants
discordant for amoxicillin exposure at 8 months of age is colored purple, and the family with infants concordant for amoxicillin exposure at 8
months of age is colored brown. Infant twin A subjects are shaded darker; twin B subjects are shaded lighter. β-lactamases were commonly present
in both members of a twin pair, and frequently persisted at more than one timepoint within a given subject. Many β-lactamases identified in the
infant fecal microbiomes were not present in the maternal microbiome
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despite inter-subject variation in exposure to amoxicillin
may reflect the sampling resolution in this small study, in
which the resistome is sampled 1 or 2 months prior to
antibiotic therapy and 3 months after antibiotic exposure.
Prior studies have shown acute antibiotic-induced perturbations in adult gut microbial community concomitant
with host antibiotic exposure, followed by partial recovery
[24, 25]. The binary data regarding presence or absence of
resistance genes generated by this study also precludes detection of any changes in the relative abundance of certain
taxa following antibiotic exposure. Future studies including more frequent fecal sampling surrounding the time of
host antibiotic exposure and additional data regarding the
abundance of selected resistance genes may illuminate
more acute and transient antibiotic effects that our study
was not designed or powered to detect.
Understanding patterns of gut-associated resistance
gene dissemination within human communities has epidemiologic implications. We found that sharing of resistance genes within families was positively associated with
sharing between families, and that persistence of resistance genes within an individual over time was positively
associated with sharing with within-family sharing, but
not with between-family sharing. Co-localization with a
mobile genetic element was not significantly correlated
with identification of resistance proteins in multiple individuals. This finding may be explained by undercounting mobilizable elements in this functional metagenomic
study, where nearly all contigs identified were <5 kilobases (kb). This concern is partially mitigated by the
demonstration that trends in resistance gene and
mobilization element co-localization predicted by smallinsert functional metagenomics are recapitulated by
matched calculations from bacterial whole genome sequences [26]. Alternatively, our data may suggest that
the distribution of gut-associated resistance genes primarily reflects the prevalence of specific host bacteria
within the human community, rather than any association with mobile genetic elements, as has been demonstrated in soil microbiomes and resistomes [26]. The
positive association between persistence within individuals over time and within-family sharing but not
between-family sharing may be a reflection of host genetics or shared environment shaping microbial communities; microbes that are more likely to persist within an
individual may also be more likely to colonize close relatives. The potential role for examining genes shared
within families to detect clinically important resistance
genes emerging human communities warrants further
investigation.
Chloramphenicol resistance was universal in all subjects at all timepoints, consistent with our previous
resistome study of single timepoint samples of unrelated
infants and children [5] as well as with prior studies
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showing highly prevalent chloramphenicol resistance in
adult populations [27]. The reason for universal chloramphenicol resistance is unclear. Agricultural use of
chloramphenicol providing selection pressure (the “farm
to fork” model [27]) is a potential factor; alternatively,
chloramphenicol resistance genes may play a yet-to-be
determined role as a core functional component of the
gut microbiome [20]. Chloramphenicol resistance genes
demonstrated a developmental progression from a neonatal to an adult-like state. The infant chloramphenicol
resistome was initially dominated by multidrug efflux
pumps, which were uncommonly found in maternal
chloramphenicol selections, and became less common
over time. Because most of the source contigs for these
multidrug efflux pumps had high identity to Enterobacteriaceae, it is unlikely that the predominance of multidrug efflux pumps in early infancy is a result of
bifidobacteria- or lactobacilli-enriched infantile gut microbial communities. Importantly, our past studies with
adult and pediatric human microbiome samples have
demonstrated functional capture of numerous resistance
genes of Firmicutes, Bacteroidetes, and Actinobacteria
origin, without over-representation of Proteobacterial
genes [5, 28], suggesting the observed Enterobacteriaceae multidrug efflux pump enrichment signal is not an
artifact of cloning bias in our E. coli screening host. Prior
studies have shown that Enterobacteriaceae are enriched in
the gut microbial communities of young infants and decrease with time [15, 29]; the observed decrease in
chloramphenicol-resistant multidrug efflux pumps during
the first year of life in this cohort may be a reflection of
maturation of the gut microbial community. Chloramphenicol acetyltransferases were more commonly found in
mothers, although they were identified in all infant subjects
at some timepoint. This finding of cryptic organisms as an
important source of novel chloramphenicol resistance
genes is consistent with our prior survey of the antibiotic
resistome of healthy children [5].

Conclusions
This longitudinal study of three pairs of healthy twins
and their mothers shows that a diverse gut resistome is
present in the first 2 months of life. This confirms our
prior hypothesis that multiple antibiotic resistance is
present in very young infants [5], and underscores the
importance of future study to understand the environmental determinants of resistome establishment in the
first weeks of life. Prior studies have shown that gut microbial communities and community-encoded microbial functions of twin siblings are similar to each other
[13, 15, 20, 21]; our study shows that the gut resistomes
of twin pairs also remain similar to each other throughout the first year of life, reinforcing the influence of
shared host genetic and environmental variables driving
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resistome development. Infant gut resistomes were no
more similar to those of their mothers than to unrelated infants, indicating that factors other than the maternal gut microbial composition are critical for
shaping the infant fecal microbiome. Recent work has
shown that microbial communities on environmental
surfaces in hospitals and homes significantly affect the
composition of host-associated microbial communities
for humans in those habitats [30, 31], and soil microbes
have also been found to have resistance genes identical
to those in human pathogens [32]. Although antibioticresistant bacteria have been identified on many food
products [33–35], 1–2-month-old infants are unlikely
to have substantial solid food exposure, and thus environmental surface exposures are more likely to shape
the gut resistome of young infants. The association between resistance genes that are shared within and between families suggests a potential role for surveillance
of resistance genes within families as a first indicator of
resistance genes that are becoming prevalent in the larger community. Infants tended to have resistance to
clinically important broad-spectrum β-lactam antibiotics that their mothers lacked; this, in combination
with the dissimilarity between the populations of infant
and maternal β-lactamases, suggests that understanding
the factors predisposing infant microbiota to harbor these
undesirable β-lactamases may lead to better understanding
of the determinants of widespread broad-spectrum βlactamase resistance in human communities. Finally, we
describe a developmental progression for a potentially
core microbial function of chloramphenicol resistance,
which progresses from Enterobacteriaceae multidrug efflux pumps in early infancy to an adult-like population of
chloramphenicol acetyltransferases that are often encoded
by cryptic microbes, providing new insight into the development of microbiome functions in the early life of the
human host.

Methods
Maternal stools were collected at delivery, and infant fecal
samples were collected at 1–2 (baseline), 6–7 (30 days after
solid food initiation), and 11 months of age (post-antibiotic
exposure). All fecal samples used in this study were collected with informed consent for the St. Louis Neonatal
Microbiome Initiative (P.I. Dr. Barbara Warner). This study
and the St. Louis Neonatal Microbiome Initiative were approved by Washington University’s Institutional Review
Board (IRB# 201205152 and 201105492, respectively).
Demographics and clinical metadata were securely stored
in a RedCap [36] database. The resistomes encoded by
these infant and maternal fecal samples were characterized
using functional metagenomic selections [4, 5, 32]. We
constructed metagenomic libraries by shotgun cloning
one- to five-Kb DNA fragments from the 21 fecal samples
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(Additional file 1: Table S1) into a pZE21 plasmid vector,
and transforming the plasmids into E. coli as previously
described [5]. These libraries were screened for resistance
against 18 antibiotics representing eight drug classes
(β-lactams, tetracyclines, aminoglycosides, amphenicols,
quinolones, sulfonamides, polymyxins, and cycloserine).
Resistance was observed to 16 of the 18 antibiotics tested
(Additional file 1: Table S2); resistance-conferring fragments were sequenced, assembled, and annotated using
the Parallel Annotation and Reassembly of Functional
Metagenomic Selections (PARFuMS) iterative assembly
pipeline [32] (see online methods). Predicted proteins
were clustered at the 97 % identity level using cd-hit
[17, 18]. Resistance proteins and mobilization elements
were identified by a previously described keyword
string search of predicted proteins annotated by the
PARFuMS computational pipeline [5]. Statistical analysis was performed on these 97 % ID clusters using
SAS version 9.3. Analyses on resistance protein clusters
were performed using log-linear models assuming a
negative binomial distribution of protein cluster counts.
Tables of pairwise sample similarity between all samples were calculated using the binary Jaccard distance
metric from the QIIME package [37].
Availability of supporting data

The data reported in this paper are tabulated in Additional
file 1 and archived in NCBI Genbank (BioProject ID
PRJNA287613).

Additional file
Additional file 1: Supplementary materials. Table S1. Twin
demographics. Table S2. Antibiotics used for functional selections.
Table S3. Log-linear model of multidrug efflux pump protein clusters
identified in beta-lactam selections following amoxicillin exposure.
Table S4–S5. Log-linear model of within-family and between-family sharing
of resistance-associated protein clusters. Table S6. Log-linear model of
multidrug efflux pump protein clusters identified in chloramphenicol
selections in infants and mothers. Table S7. Log-linear model of multidrug
efflux pump protein clusters identified in chloramphenicol selections in
infants over time. Table S8–S9. Log-linear model of chloramphenicol
acetyltransferase protein clusters identified in chloramphenicol selections in
infants over time. Table S10. Log-linear model of within-family sharing,
between-family sharing, and appearance of resistance-associated protein
clusters at difference points in time. Figure S1. Antibiotic resistance
phenotypes. Figure S2. Beta-lactam resistance genotype and
phenotype. Figure S3. Twin infant fecal resistomes resemble those of their
siblings at each timepoint.
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